McKesson raises annual profit forecast on strong growth in specialty drug business

Drug distributor McKesson on Wednesday raised its annual profit forecast after beating first-quarter earnings estimates, on ​strength in its oncology and specialty drug businesses.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。